Lever Time - Premium
from The Lever
INSIDE THE STORY: How Big Pharma Actually Spends Its Massive Profits
New research shows that pharmaceutical companies have spent more on enriching shareholders than drug research and development over the past decade.
This mini-episode is part of our Inside The Story series, where we highlight some of The Lever’s original reporting and speak with the journalists who wrote the story. Frank Cappello speaks with Julia Rock, who details their new story published by The Lever:
Pharmaceutical giants rang in the new year by quietly announcing price hikes in the United States on more than 350 drugs — and they continue to insist these price hikes are necessary for innovation. But new research shows that the business model of America’s largest pharmaceutical companies involves far more spending on enriching shareholders and executives than on research and development.
To read the full story, click here.